For: | Hussain Z, Ali SS, Husain SA, Raish M, Sharma DR, Kar P. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India. World J Gastroenterol 2005; 11(45): 7165-7168 [PMID: 16437665 DOI: 10.3748/wjg.v11.i45.7165] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i45/7165.htm |
Number | Citing Articles |
1 |
Ilija Rosic, Sead Malicevic, Snezana Medic, Clemens Vlasich. Immune response by athletes to hepatitis B vaccination. Vaccine 2008; 26(26): 3190 doi: 10.1016/j.vaccine.2008.03.051
|
2 |
Chaoshuang Lin, Jianyun Zhu, Yubao Zheng, Youming Chen, Zhebin Wu, Yutian Chong, Zhiliang Gao. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders. Journal of Infection 2010; 60(4): 264 doi: 10.1016/j.jinf.2010.01.011
|
3 |
Ioanna Aggeletopoulou, Panagiota Davoulou, Christos Konstantakis, Konstantinos Thomopoulos, Christos Triantos. Response to hepatitis B vaccination in patients with liver cirrhosis. Reviews in Medical Virology 2017; 27(6) doi: 10.1002/rmv.1942
|
4 |
Senoo-Dogbey Vivian Efua, Wuaku Delali Adwoa, Mumuni Adiza Atoko. Adherence to the three-component Hepatitis B virus vaccination protocol among healthcare workers in hepatitis B virus endemic settings in Ghana. Vaccine: X 2024; 16: 100421 doi: 10.1016/j.jvacx.2023.100421
|
5 |
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, Abyson Joseph, Ruchir Rastogi, Nupur Mehrotra Arora, Prabuddha K. Kundu. Platforms, advances, and technical challenges in virus-like particles-based vaccines. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1123805
|
6 |
Rafael Travassos, Sofia A. Martins, Ana Fernandes, João D. G. Correia, Rita Melo. Tailored Viral-like Particles as Drivers of Medical Breakthroughs. International Journal of Molecular Sciences 2024; 25(12): 6699 doi: 10.3390/ijms25126699
|
7 |
Hyuk-Seong Seo, Jin-Seung Park, Kyung-Yeon Han, Kyung-Dong Bae, Sang Jeom Ahn, Hyun Ah Kang, Jeewon Lee. Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha. Vaccine 2008; 26(33): 4138 doi: 10.1016/j.vaccine.2008.05.070
|
8 |
G.H. Ghorbani, S.M. Alavian, A.A. Esfahani. Long-Term Protection of Hepatitis B Vaccine in Adult. Journal of Medical Sciences 2007; 7(7): 1214 doi: 10.3923/jms.2007.1214.1217
|
9 |
Sarah F. Schillie, Philip R. Spradling, Trudy V. Murphy. Immune Response of Hepatitis B Vaccine Among Persons With Diabetes. Diabetes Care 2012; 35(12): 2690 doi: 10.2337/dc12-0312
|
10 |
Hui Jin, Zhaoying Tan, Xuefeng Zhang, Bei Wang, Yueyuan Zhao, Pei Liu, Hiroshi Nishiura. Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials. PLOS ONE 2015; 10(7): e0133464 doi: 10.1371/journal.pone.0133464
|
11 |
Kousar Smailnejad-Ganji, Mousa Mohammadnia-Afrouzi, Iraj Mohammad-Zadeh, Mojdeh Ghias Tabari, Azam Bolhassani, Zahra Moulana, Mojgan Bagherzadeh, Mehdi Shahbazi. Relationship Between HBsAb Response, Expression of TLR 2, 3 and 4, and Birth Season in 3 - 5-Year-Old Children. Jundishapur Journal of Microbiology 2019; 12(8) doi: 10.5812/jjm.91649
|
12 |
Seyed‐Moayed Alavian, Morteza Izadi, Ali‐Akbar Zare, Maryam Moghani Lankarani, Shervin Assari, Mohammad‐Mahdi Vardi. Survey of the level of anti‐HBs antibody titer in vaccinated Iranian general dentists. Special Care in Dentistry 2008; 28(6): 265 doi: 10.1111/j.1754-4505.2008.00052.x
|
13 |
Ian Francis Cook. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008; 26(29-30): 3551 doi: 10.1016/j.vaccine.2008.04.054
|